Webex Link: https://uwhealth.webex.com/uwhealth/j.php?MTID=m398b5099541b81f1b40740bd5e213c1f

Learning Objectives:

  • Summarize schizophrenia as a disease state, guideline recommendations, and long-term management.​

  • Describe Cobenfy's mechanism of action, receptor binding profile, and common side effects compared to current treatment options.

  • Explain Cobenfy's background, clinical trial development, and place in therapy.​

Session date: 
04/24/2025 - 2:00pm to 3:00pm CDT
Location: 
In-person and Virtually
Will be determined by room availability
600 Highland Ave
Madison, WI 53705
United States
  • 1.00 ACPE Contact Hours - Pharmacist
  • 1.00 University of Wisconsin–Madison Continuing Education Hours

Please login or register to take this course.
Presenter(s): 
Blake O'Connor, Yoonsoo Kim, and Sydney Mckersie